ArticlePublic health weekly report2026
Preventive Measures against Avian Influenza Infection in Humans in the Republic of Korea, 2024-2025.
Article in Public health weekly report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preventive Response to Avian Influenza Infection in Humans in the Metropolitan Region, 2025-2026.Public health weekly report · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The present report summarizes the key measures and outcomes implemented by the Korea Disease Control and Prevention Agency (KDCA) during the 2024-2025 season (October 1, 2024-September 11, 2025) to prevent human infection with avian influenza (AI). It also provides evidence for future preparedness and responses to emerging influenza. Methods: AI human infection, a Category I National Notifiable Infectious Disease, is mainly transmitted through contact with infected animals or contaminated environments. The KDCA operated a Central AI Human Infection Response Task Force, supported local governments, and strengthened One Health collaboration with the MAFRA (Ministry of Agriculture, Food and Rural Affairs) and the MCEE (Ministry of Climate, Energy and Environment). Primary actions encompassed seasonal influenza vaccination for AI responders; updated guidelines; three joint ministerial meetings; reinforced hotline operations, newly established joint field training; and training programs for AI responders. Results: During the 2024-2025 season, 52 cases of highly pathogenic AI were reported in poultry, 43 cases in wild birds, and 1 case in a wild mammal (leopard cat). A total of 7,790 high-risk individuals were placed under a 10-day active surveillance. All suspected cases tested negative, and no human infections were confirmed. Detection of AI in a wild mammal, along with the persistent global risk, prompted the KDCA to expand its task force to a year-round system in 2025 and strengthen inter-ministerial collaboration. Conclusions: Relative to previous season, highly pathogenic avian influenza cases increased from 51 to 96, and the number of high-risk contacts rose markedly from 3,986 to 7,790 cases; however, the 2024-2025 season concluded with no confirmed human case. The KDCA will continue One Health-based preparedness to prevent human AI infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.